Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Heart Failure Drugs: Diuretics01:22

Heart Failure Drugs: Diuretics

346
Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
346
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

1
Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
1
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System01:26

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

394
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
394
Heart Failure Drugs: Inotropic Agents01:26

Heart Failure Drugs: Inotropic Agents

527
Positive inotropic agents are commonly used as the first line of treatment for heart failure. One such agent is digoxin, derived from the genus Digitalis, which has been known for centuries but effectively utilized since 1785. However, these cardiac glycosides can have potentially toxic effects due to their mechanism of action, which involves inhibiting Na+/K+-ATPase and increasing contractility. Digoxin is absorbed orally and distributed in various tissues, including the CNS. It has a long...
527
Heart Failure V: Medical Management01:30

Heart Failure V: Medical Management

1
Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
1
Heart Failure VI: Adjunct Therapies01:22

Heart Failure VI: Adjunct Therapies

1
Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
1

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Cancer as a Hidden Catalyst: Rethinking Postoperative Atrial Fibrillation After Cardiac Surgery.

Journal of clinical medicine·2026
Same author

Robotic-Assisted Thoracic Surgery in the Immunotherapy Era: Navigating Altered Anatomy, Oncologic Precision, and the Future of Integrated Platforms.

Journal of clinical medicine·2026
Same author

The Legacy of the First Valve: Outcomes of Redo Surgical Aortic Valve Replacement After Prior Transcatheter Versus Prior Surgical Aortic Valve Replacement-A Narrative Review.

Journal of clinical medicine·2026
Same author

Sotatercept as an Add-On to Background Therapy in Idiopathic Pulmonary Arterial Hypertension: Insights from a Real-World Cohort.

Pharmaceuticals (Basel, Switzerland)·2026
Same author

Artificial Intelligence-Driven Hypertension Management: Implications for Quality Improvement and Prevention of End-Organ Damage.

Life (Basel, Switzerland)·2026
Same author

Acute Aortic Dissection in Women: A Comprehensive Review of Sex-Specific Differences, Clinical Management, and Outcomes.

Journal of cardiovascular development and disease·2026
Same journal

RETRACTED: Zito Marino et al. AXL and MET Tyrosine Kinase Receptors Co-Expression as a Potential Therapeutic Target in Malignant Pleural Mesothelioma. <i>J. Pers. Med.</i> 2022, <i>12</i>, 1993.

Journal of personalized medicine·2026
Same journal

Correction: Rao et al. Ensemble Deep-Learning-Based Prognostic and Prediction for Recurrence of Sporadic Odontogenic Keratocysts on Hematoxylin and Eosin Stained Pathological Images of Incisional Biopsies. <i>J. Pers. Med.</i> 2022, <i>12</i>, 1220.

Journal of personalized medicine·2026
Same journal

Three-Dimensional Bronchovascular Modelling in Sublobar Pulmonary Resection: A Tool for Personalised Thoracic Surgery.

Journal of personalized medicine·2026
Same journal

Serum Albumin, Globulin and Albumin-Globulin Ratios as Biomarkers of Clinical Outcomes in COVID-19 Pneumonia.

Journal of personalized medicine·2026
Same journal

New Advances and Perspectives in Ophthalmology: Progress and Modern Challenges Toward Personalized Eye Care.

Journal of personalized medicine·2026
Same journal

Bridging Ancestry-Stratified Bias in Pharmacogenomics AI: Toward Metabolomics-Inclusive Multi-Omics Precision Medicine.

Journal of personalized medicine·2026
See all related articles

Related Experiment Video

Updated: Jun 9, 2025

A Surgical Model of Heart Failure with Preserved Ejection Fraction in Tibetan Minipigs
07:09

A Surgical Model of Heart Failure with Preserved Ejection Fraction in Tibetan Minipigs

Published on: February 18, 2022

1.8K

Targeting Sodium in Heart Failure.

Filippos Triposkiadis1, Andrew Xanthopoulos2, John Skoularigis2

  • 1School of Medicine, European University Cyprus, 2404 Nicosia, Cyprus.

Journal of Personalized Medicine
|October 25, 2024
PubMed
Summary
This summary is machine-generated.

Heart failure (HF) management requires balancing sodium (Na+) and water. New methods like 23Na+ MRI and wearable sensors may improve monitoring of Na+ levels and congestion in HF patients.

Keywords:
congestionhypertonic salinesensorssodiumurinary spot

More Related Videos

Assessment of Sarcoplasmic Reticulum Calcium Reserve and Intracellular Diastolic Calcium Removal in Isolated Ventricular Cardiomyocytes
11:00

Assessment of Sarcoplasmic Reticulum Calcium Reserve and Intracellular Diastolic Calcium Removal in Isolated Ventricular Cardiomyocytes

Published on: September 18, 2017

10.1K
Author Spotlight: Investigating HR-Dependent Cardiac Function in Mouse Models Through a Novel Atrial-Pacing Approach
07:49

Author Spotlight: Investigating HR-Dependent Cardiac Function in Mouse Models Through a Novel Atrial-Pacing Approach

Published on: July 21, 2023

1.3K

Related Experiment Videos

Last Updated: Jun 9, 2025

A Surgical Model of Heart Failure with Preserved Ejection Fraction in Tibetan Minipigs
07:09

A Surgical Model of Heart Failure with Preserved Ejection Fraction in Tibetan Minipigs

Published on: February 18, 2022

1.8K
Assessment of Sarcoplasmic Reticulum Calcium Reserve and Intracellular Diastolic Calcium Removal in Isolated Ventricular Cardiomyocytes
11:00

Assessment of Sarcoplasmic Reticulum Calcium Reserve and Intracellular Diastolic Calcium Removal in Isolated Ventricular Cardiomyocytes

Published on: September 18, 2017

10.1K
Author Spotlight: Investigating HR-Dependent Cardiac Function in Mouse Models Through a Novel Atrial-Pacing Approach
07:49

Author Spotlight: Investigating HR-Dependent Cardiac Function in Mouse Models Through a Novel Atrial-Pacing Approach

Published on: July 21, 2023

1.3K

Area of Science:

  • Cardiology
  • Nephrology
  • Biomedical Engineering

Background:

  • Heart failure (HF) is significantly impacted by disruptions in sodium (Na+) and water balance, leading to fluid retention and edema.
  • Incomplete decongestion in HF patients correlates with poorer outcomes, highlighting the need for effective Na+-targeting interventions.
  • Current HF management often involves quadruple therapy, but optimizing Na+-targeting treatments remains a challenge.

Purpose of the Study:

  • To evaluate the role and effectiveness of Na+-targeting interventions in managing congestion in heart failure patients.
  • To explore advanced methods for monitoring tissue sodium (Na+) and guiding Na+-targeting treatments in HF.
  • To investigate the clinical significance of the 3-compartment model of Na+ storage in HF.

Main Methods:

  • Review of existing literature on Na+-targeting interventions (dietary restriction, hypertonic saline, diuretics) in HF.
  • Discussion of novel monitoring techniques including spot urinary sodium, 23Na+ magnetic resonance imaging (MRI), and wearable sensors.
  • Exploration of the 3-compartment model of Na+ storage, emphasizing non-osmotic accumulation in tissues like skin.

Main Results:

  • Incomplete decongestion adversely affects HF outcomes, underscoring the importance of effective Na+ and water balance management.
  • Existing metrics for HF severity have limitations in predicting and managing congestion, potentially leading to dysnatremias.
  • Emerging evidence suggests spot urinary sodium can guide Na+-targeting interventions in both acute and chronic HF.
  • 23Na+-MRI and wearable sensors offer promising avenues for accurate tissue Na+ quantification and monitoring.

Conclusions:

  • Optimizing Na+-targeting interventions is crucial for selected HF patients on quadruple therapy.
  • Advanced monitoring tools like 23Na+-MRI and wearable sensors are essential for precise tissue Na+ assessment and guiding treatment.
  • Further research is needed to elucidate the clinical implications of tissue Na+ storage and its role in HF morbidity and mortality.